LVT 0.00% 0.6¢ livetiles limited

@LT_InvestorIt depends if cash receipts will be maintained at...

  1. 168 Posts.
    lightbulb Created with Sketch. 193
    @LT_Investor

    It depends if cash receipts will be maintained at $14.6m, reduce through seasonality or increase in line with ARR over the next 12 months. Based on current ARR of $62.8m, cash receipts should reach $15.7m per quarter on average.

    I think what's interesting (based on the most recent quarter), is it seems like much of the lag between ARR and cash collection has reduced. I always thought it was strange that there was such a large delay between ARR and cash receipts. The only thing I can put it down to is the acquisitions inorganically boosting ARR (and seasonal payment cycles from those customers) and the conclusion of the N3 partnership distorting cash collection numbers. Hopefully things will be more predictable now that we're clear of all of those events.

    In terms of current op ex, I'd be keen to understand if the R&D costs incurred this past quarter are recurring or were just a one-off increase as they invested upfront. Most other costs seem to have normalised.
    Last edited by badkerning: 30/07/21
 
watchlist Created with Sketch. Add LVT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.